Show simple item record

dc.contributor.authorGaba, F
dc.contributor.authorBlyuss, O
dc.contributor.authorLiu, X
dc.contributor.authorGoyal, S
dc.contributor.authorLahoti, N
dc.contributor.authorChandrasekaran, D
dc.contributor.authorKurzer, M
dc.contributor.authorKalsi, J
dc.contributor.authorSanderson, S
dc.contributor.authorLanceley, A
dc.contributor.authorAhmed, M
dc.contributor.authorSide, L
dc.contributor.authorGentry-Maharaj, A
dc.contributor.authorWallis, Y
dc.contributor.authorWallace, A
dc.contributor.authorWaller, J
dc.contributor.authorLuccarini, C
dc.contributor.authorYang, X
dc.contributor.authorDennis, J
dc.contributor.authorDunning, A
dc.contributor.authorLee, A
dc.contributor.authorAntoniou, AC
dc.contributor.authorLegood, R
dc.contributor.authorMenon, U
dc.contributor.authorJacobs, I
dc.contributor.authorManchanda, R
dc.date.accessioned2020-06-09T14:26:34Z
dc.date.available2020-06-09T14:26:34Z
dc.date.issued2020-05-15
dc.identifier.citationGaba, F.; Blyuss, O.; Liu, X.; Goyal, S.; Lahoti, N.; Chandrasekaran, D.; Kurzer, M.; Kalsi, J.; Sanderson, S.; Lanceley, A.; Ahmed, M.; Side, L.; Gentry-Maharaj, A.; Wallis, Y.; Wallace, A.; Waller, J.; Luccarini, C.; Yang, X.; Dennis, J.; Dunning, A.; Lee, A.; Antoniou, A.C.; Legood, R.; Menon, U.; Jacobs, I.; Manchanda, R. Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention. Cancers 2020, 12, 1241.en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/64757
dc.description.abstractUnselected population-based personalised ovarian cancer (OC) risk assessment combining genetic/epidemiology/hormonal data has not previously been undertaken. We aimed to perform a feasibility study of OC risk stratification of general population women using a personalised OC risk tool followed by risk management. Volunteers were recruited through London primary care networks. Inclusion criteria: women ≥18 years. Exclusion criteria: prior ovarian/tubal/peritoneal cancer, previous genetic testing for OC genes. Participants accessed an online/web-based decision aid along with optional telephone helpline use. Consenting individuals completed risk assessment and underwent genetic testing (BRCA1/BRCA2/RAD51C/RAD51D/BRIP1, OC susceptibility single-nucleotide polymorphisms). A validated OC risk prediction algorithm provided a personalised OC risk estimate using genetic/lifestyle/hormonal OC risk factors. Population genetic testing (PGT)/OC risk stratification uptake/acceptability, satisfaction, decision aid/telephone helpline use, psychological health and quality of life were assessed using validated/customised questionnaires over six months. Linear-mixed models/contrast tests analysed impact on study outcomes. Main outcomes: feasibility/acceptability, uptake, decision aid/telephone helpline use, satisfaction/regret, and impact on psychological health/quality of life. In total, 123 volunteers (mean age = 48.5 (SD = 15.4) years) used the decision aid, 105 (85%) consented. None fulfilled NHS genetic testing clinical criteria. OC risk stratification revealed 1/103 at ≥10% (high), 0/103 at ≥5%–<10% (intermediate), and 100/103 at <5% (low) lifetime OC risk. Decision aid satisfaction was 92.2%. The telephone helpline use rate was 13% and the questionnaire response rate at six months was 75%. Contrast tests indicated that overall depression (p = 0.30), anxiety (p = 0.10), quality-of-life (p = 0.99), and distress (p = 0.25) levels did not jointly change, while OC worry (p = 0.021) and general cancer risk perception (p = 0.015) decreased over six months. In total, 85.5–98.7% were satisfied with their decision. Findings suggest population-based personalised OC risk stratification is feasible and acceptable, has high satisfaction, reduces cancer worry/risk perception, and does not negatively impact psychological health/quality of life.en_US
dc.format.extent1241 - 1241
dc.languageen
dc.language.isoenen_US
dc.publisherMDPI AGen_US
dc.relation.ispartofCancers
dc.rightsCreative Commons Attribution (CC BY) license
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titlePopulation Study of Ovarian Cancer Risk Prediction for Targeted Screening and Preventionen_US
dc.typeArticleen_US
dc.rights.holder© 2020 by the authors.
dc.identifier.doi10.3390/cancers12051241
pubs.issue5en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume12en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.funder.project483cf8e1-88a1-4b8b-aecb-8402672d45f8en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution (CC BY) license
Except where otherwise noted, this item's license is described as Creative Commons Attribution (CC BY) license